Please login to the form below

Not currently logged in
Email:
Password:

Biogen appoints Jeff Capello as executive VP and CFO

He will lead the company's business and finance planning functions

Jeff CapelloBiotechnology company Biogen has appointed Jeff Capello as its executive vice president and chief financial officer, roles which will see him lead the company’s business planning, tax, treasury, internal audit, accounting and investor relations functions.

Reporting to chief executive officer of Biogen, Michel Vounatsos, Capello will also become a member of the executive committee and he will be based in its Massachusetts office in the US.

He said: “I am very excited to join Biogen, a company which is recognised as a pioneer and a leader in treating neurological diseases and I look forward to working with colleagues around the world in our mission to make a difference in the lives of patients.”

Capello brings 26 years of experience in finance to Biogen, with his most recent role being executive vice president and chief financial officer at Beacon Health Options.

His career experience has seen him serve in various positions for Monomy Advisors, Ortho Clinical Diagnostics, Boston Scientific Corporation and Perkin Elmer.

Vounatsos said: “We are fortunate to have Jeff join Biogen given the depth and breadth of his experience.

“He comes to Biogen at an exciting time as we execute our business strategy, pursue business development opportunities and build our pipeline.”

5th December 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
HAVAS LYNX

Welcome to HAVAS LYNX, a leading global healthcare communications group....

Latest intelligence

Finding the patient voice
How patients feel and speak about clinical trials...
Six Factors to Consider When Designing Advisory Boards
...
The good, the bad and the ugly
Tracking the pharmaceutical industry’s 2017 evolution and assessing how things may shape up in 2018 - it’s a trilogy of trends...

Infographics